Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-29

Clinical Trial Update: Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin glargine to liraglutide after failure of oral agents in Type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus (insulin glargine)
  • Victoza (Liraglutide)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2014-01-29